Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Software | 25 | 2023 | 4392 | 2.240 |
Why?
|
Computer Graphics | 7 | 2008 | 362 | 1.360 |
Why?
|
Computational Biology | 17 | 2016 | 3564 | 1.300 |
Why?
|
Proteome | 6 | 2023 | 1759 | 1.070 |
Why?
|
Gene Expression Profiling | 32 | 2016 | 9494 | 1.050 |
Why?
|
Sequence Analysis, DNA | 11 | 2017 | 4910 | 0.980 |
Why?
|
Algorithms | 21 | 2016 | 13761 | 0.840 |
Why?
|
Oligonucleotide Array Sequence Analysis | 18 | 2013 | 4035 | 0.700 |
Why?
|
Information Storage and Retrieval | 7 | 2009 | 835 | 0.680 |
Why?
|
Database Management Systems | 6 | 2009 | 287 | 0.680 |
Why?
|
User-Computer Interface | 9 | 2015 | 1439 | 0.650 |
Why?
|
Databases, Protein | 4 | 2007 | 374 | 0.600 |
Why?
|
Protein Interaction Mapping | 4 | 2007 | 643 | 0.560 |
Why?
|
Flow Cytometry | 6 | 2010 | 6092 | 0.550 |
Why?
|
Cell Physiological Phenomena | 2 | 2006 | 153 | 0.520 |
Why?
|
Vegetables | 1 | 2020 | 1146 | 0.520 |
Why?
|
RNA Editing | 1 | 2016 | 156 | 0.520 |
Why?
|
Databases, Genetic | 8 | 2013 | 1800 | 0.510 |
Why?
|
Models, Biological | 8 | 2012 | 9810 | 0.510 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 242 | 0.490 |
Why?
|
Chromatin Immunoprecipitation | 4 | 2013 | 898 | 0.460 |
Why?
|
Mathematical Concepts | 1 | 2012 | 58 | 0.440 |
Why?
|
RNA Splicing | 1 | 2016 | 870 | 0.420 |
Why?
|
Organ Specificity | 2 | 2016 | 2034 | 0.420 |
Why?
|
Sequence Analysis, RNA | 4 | 2016 | 2015 | 0.400 |
Why?
|
Models, Genetic | 6 | 2014 | 3522 | 0.380 |
Why?
|
Gene Expression Regulation | 8 | 2016 | 12285 | 0.370 |
Why?
|
Biometry | 4 | 2010 | 549 | 0.370 |
Why?
|
High-Throughput Screening Assays | 2 | 2015 | 926 | 0.350 |
Why?
|
Genes, Lethal | 1 | 2008 | 255 | 0.330 |
Why?
|
Chromosome Mapping | 2 | 2006 | 4813 | 0.300 |
Why?
|
Signal Transduction | 8 | 2016 | 23705 | 0.300 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1883 | 0.300 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4355 | 0.300 |
Why?
|
RNA | 1 | 2016 | 2607 | 0.300 |
Why?
|
Data Mining | 1 | 2012 | 552 | 0.300 |
Why?
|
Epistasis, Genetic | 1 | 2008 | 369 | 0.290 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 814 | 0.290 |
Why?
|
Saccharomyces cerevisiae | 3 | 2008 | 2865 | 0.280 |
Why?
|
Genomics | 9 | 2017 | 5338 | 0.270 |
Why?
|
Cell Separation | 3 | 2010 | 1818 | 0.270 |
Why?
|
Genetics, Population | 2 | 2009 | 992 | 0.260 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2004 | 129 | 0.260 |
Why?
|
Sequence Alignment | 3 | 2013 | 2285 | 0.250 |
Why?
|
Models, Statistical | 5 | 2021 | 5091 | 0.250 |
Why?
|
Proteins | 3 | 2009 | 6071 | 0.240 |
Why?
|
DNA Probes | 1 | 2004 | 571 | 0.230 |
Why?
|
Diet | 1 | 2020 | 7647 | 0.220 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2013 | 3670 | 0.210 |
Why?
|
Exons | 3 | 2016 | 2463 | 0.210 |
Why?
|
MyoD Protein | 2 | 2012 | 157 | 0.200 |
Why?
|
Genome | 3 | 2010 | 1748 | 0.190 |
Why?
|
Genome, Human | 7 | 2016 | 4466 | 0.190 |
Why?
|
DNA Mutational Analysis | 3 | 2012 | 4285 | 0.190 |
Why?
|
Databases, Factual | 4 | 2011 | 7901 | 0.180 |
Why?
|
Gene Expression | 4 | 2012 | 7944 | 0.180 |
Why?
|
Natural Language Processing | 1 | 2006 | 954 | 0.180 |
Why?
|
Terminology as Topic | 1 | 2006 | 1612 | 0.180 |
Why?
|
Alternative Splicing | 2 | 2016 | 1124 | 0.180 |
Why?
|
Computer Simulation | 7 | 2007 | 6121 | 0.170 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2008 | 1961 | 0.170 |
Why?
|
Artifacts | 1 | 2007 | 1912 | 0.170 |
Why?
|
Bayes Theorem | 2 | 2005 | 2064 | 0.170 |
Why?
|
Data Interpretation, Statistical | 5 | 2008 | 2748 | 0.160 |
Why?
|
Protein Binding | 3 | 2016 | 9555 | 0.150 |
Why?
|
Transcription Factors | 6 | 2013 | 11942 | 0.150 |
Why?
|
Documentation | 1 | 2003 | 870 | 0.150 |
Why?
|
Systems Biology | 3 | 2011 | 489 | 0.150 |
Why?
|
Transcription, Genetic | 5 | 2016 | 7877 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2016 | 8560 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 522 | 0.140 |
Why?
|
Demography | 1 | 2020 | 1627 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2012 | 1136 | 0.140 |
Why?
|
Base Sequence | 8 | 2014 | 13171 | 0.130 |
Why?
|
Fruit | 1 | 2020 | 1119 | 0.130 |
Why?
|
Information Dissemination | 4 | 2017 | 1099 | 0.120 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 332 | 0.120 |
Why?
|
Eating | 1 | 2020 | 1459 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2012 | 791 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1586 | 0.120 |
Why?
|
MicroRNAs | 4 | 2011 | 3618 | 0.120 |
Why?
|
Introns | 1 | 2016 | 994 | 0.120 |
Why?
|
Limonins | 1 | 2012 | 22 | 0.110 |
Why?
|
Patient Care | 1 | 2018 | 620 | 0.110 |
Why?
|
Energy Intake | 1 | 2020 | 2156 | 0.110 |
Why?
|
beta-Defensins | 1 | 2011 | 58 | 0.110 |
Why?
|
Programming Languages | 2 | 2015 | 155 | 0.110 |
Why?
|
Thrombospondins | 1 | 2012 | 192 | 0.110 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 1 | 2011 | 48 | 0.110 |
Why?
|
Humans | 40 | 2023 | 715594 | 0.100 |
Why?
|
Reproducibility of Results | 10 | 2016 | 19529 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3252 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2016 | 1691 | 0.100 |
Why?
|
Genetic Variation | 1 | 2006 | 6659 | 0.100 |
Why?
|
Retroelements | 1 | 2011 | 159 | 0.100 |
Why?
|
SOXB1 Transcription Factors | 1 | 2012 | 290 | 0.100 |
Why?
|
Research Design | 1 | 2007 | 5914 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2010 | 109 | 0.100 |
Why?
|
Quality Control | 3 | 2008 | 868 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 386 | 0.100 |
Why?
|
Estrogens | 2 | 2012 | 1529 | 0.100 |
Why?
|
HLA-DR Antigens | 2 | 2010 | 693 | 0.100 |
Why?
|
Medical Informatics | 1 | 2017 | 735 | 0.100 |
Why?
|
Epigenomics | 2 | 2012 | 805 | 0.090 |
Why?
|
Karyotyping | 3 | 2012 | 1262 | 0.090 |
Why?
|
Muscle Development | 1 | 2012 | 290 | 0.090 |
Why?
|
Gene Amplification | 2 | 2012 | 1078 | 0.090 |
Why?
|
Virus Integration | 1 | 2012 | 300 | 0.090 |
Why?
|
Urotensins | 1 | 2009 | 7 | 0.090 |
Why?
|
Gene Fusion | 1 | 2012 | 370 | 0.090 |
Why?
|
Cell Line, Tumor | 8 | 2016 | 16726 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2014 | 15606 | 0.090 |
Why?
|
Bacillus subtilis | 1 | 2012 | 361 | 0.090 |
Why?
|
Hepatitis B virus | 1 | 2012 | 459 | 0.090 |
Why?
|
Leukemia, Lymphoid | 1 | 2008 | 369 | 0.080 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2012 | 353 | 0.080 |
Why?
|
Lung Neoplasms | 4 | 2014 | 12530 | 0.080 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 183 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3193 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2014 | 2767 | 0.080 |
Why?
|
Miniaturization | 1 | 2007 | 151 | 0.080 |
Why?
|
Hepatitis B | 1 | 2012 | 651 | 0.080 |
Why?
|
Internet | 4 | 2013 | 3071 | 0.070 |
Why?
|
Microarray Analysis | 2 | 2010 | 775 | 0.070 |
Why?
|
Software Design | 1 | 2006 | 181 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2010 | 2983 | 0.070 |
Why?
|
Mutation | 7 | 2016 | 29253 | 0.070 |
Why?
|
Neuropeptides | 1 | 2012 | 936 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2007 | 484 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 3 | 2012 | 2879 | 0.070 |
Why?
|
Epithelium | 1 | 2010 | 1720 | 0.070 |
Why?
|
Chromosomes | 1 | 2008 | 597 | 0.070 |
Why?
|
Binding Sites | 5 | 2012 | 6210 | 0.070 |
Why?
|
Genetic Testing | 1 | 2018 | 3347 | 0.070 |
Why?
|
Gene Library | 1 | 2008 | 1084 | 0.070 |
Why?
|
Neurogenesis | 1 | 2012 | 817 | 0.070 |
Why?
|
DNA, Concatenated | 1 | 2004 | 3 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 3991 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1744 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4887 | 0.060 |
Why?
|
Point Mutation | 1 | 2010 | 1647 | 0.060 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 177 | 0.060 |
Why?
|
Fourier Analysis | 1 | 2005 | 457 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 716 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 4907 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2008 | 738 | 0.060 |
Why?
|
Hypermedia | 1 | 2003 | 21 | 0.060 |
Why?
|
Burkitt Lymphoma | 1 | 2005 | 364 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 23385 | 0.060 |
Why?
|
Fibrinogen | 1 | 2006 | 912 | 0.060 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 171 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2012 | 11644 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2012 | 18583 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2009 | 3569 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5246 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 1120 | 0.060 |
Why?
|
Valproic Acid | 1 | 2005 | 447 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 324 | 0.060 |
Why?
|
Cell Survival | 2 | 2016 | 6028 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 8897 | 0.060 |
Why?
|
Neoplasms | 4 | 2016 | 20515 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2443 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2005 | 500 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5319 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 657 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 1156 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2012 | 4635 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1597 | 0.050 |
Why?
|
Transplants | 1 | 2003 | 207 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 1989 | 0.050 |
Why?
|
Quantitative Trait Loci | 1 | 2009 | 1975 | 0.050 |
Why?
|
Drug Discovery | 1 | 2009 | 1054 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2012 | 2528 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1358 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 1460 | 0.050 |
Why?
|
Antigens, CD | 2 | 2010 | 4149 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2012 | 9730 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2094 | 0.050 |
Why?
|
DNA Copy Number Variations | 3 | 2012 | 1891 | 0.050 |
Why?
|
DNA | 1 | 2013 | 7084 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5933 | 0.050 |
Why?
|
Escherichia coli | 1 | 2012 | 4265 | 0.050 |
Why?
|
Probability | 1 | 2005 | 2493 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2007 | 2222 | 0.040 |
Why?
|
Mice | 7 | 2016 | 80270 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2001 | 286 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4926 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5983 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2012 | 3919 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 34429 | 0.040 |
Why?
|
Progesterone | 1 | 2001 | 734 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2309 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 801 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4104 | 0.040 |
Why?
|
Information Services | 1 | 2017 | 243 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1065 | 0.040 |
Why?
|
Animals | 9 | 2016 | 169173 | 0.030 |
Why?
|
Cell Line | 4 | 2013 | 16559 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17399 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2007 | 2810 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2005 | 1858 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2012 | 1835 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5098 | 0.030 |
Why?
|
Brain | 2 | 2016 | 25189 | 0.030 |
Why?
|
Oncogene Fusion | 1 | 2014 | 109 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3894 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5109 | 0.030 |
Why?
|
Image Enhancement | 1 | 2005 | 2977 | 0.030 |
Why?
|
Phenotype | 2 | 2008 | 16302 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10285 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14887 | 0.030 |
Why?
|
E-Box Elements | 1 | 2012 | 18 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2001 | 1336 | 0.030 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 157 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2016 | 13203 | 0.030 |
Why?
|
Genes, APC | 1 | 2012 | 160 | 0.030 |
Why?
|
Receptor, erbB-3 | 1 | 2012 | 130 | 0.030 |
Why?
|
Adult | 5 | 2021 | 212237 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 1548 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2012 | 312 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 248 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2011 | 188 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2012 | 1593 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2012 | 19892 | 0.030 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2012 | 273 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 69 | 0.030 |
Why?
|
Dioxygenases | 1 | 2012 | 313 | 0.030 |
Why?
|
Trans-Activators | 2 | 2012 | 3047 | 0.030 |
Why?
|
Histones | 2 | 2012 | 2543 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2010 | 10595 | 0.020 |
Why?
|
Fibroblasts | 2 | 2012 | 4223 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3075 | 0.020 |
Why?
|
Myoblasts | 1 | 2011 | 254 | 0.020 |
Why?
|
Myocardium | 1 | 2003 | 4904 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2012 | 297 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5995 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9544 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 749 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13635 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2006 | 20066 | 0.020 |
Why?
|
Up-Regulation | 2 | 2012 | 4303 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2010 | 778 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1100 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1268 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 548 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 339 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1832 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 725 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 847 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 11956 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 670 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2008 | 262 | 0.020 |
Why?
|
Ribonucleases | 1 | 2008 | 274 | 0.020 |
Why?
|
Blood Cells | 1 | 2010 | 318 | 0.020 |
Why?
|
Germ Cells | 1 | 2011 | 588 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9977 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 964 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40889 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4291 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 824 | 0.020 |
Why?
|
Multipotent Stem Cells | 1 | 2008 | 198 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2010 | 563 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2008 | 274 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1699 | 0.020 |
Why?
|
Regression Analysis | 2 | 2007 | 6498 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 40040 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2680 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2007 | 340 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1745 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2792 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 774 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2010 | 3424 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 995 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 885 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1079 | 0.020 |
Why?
|
Protein Kinases | 1 | 2012 | 1659 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2008 | 890 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2006 | 411 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2005 | 306 | 0.020 |
Why?
|
Vocabulary, Controlled | 1 | 2006 | 192 | 0.020 |
Why?
|
Genomic Library | 1 | 2004 | 198 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2006 | 463 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2124 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6274 | 0.020 |
Why?
|
Automation | 1 | 2006 | 589 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13619 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2006 | 1000 | 0.020 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2007 | 525 | 0.020 |
Why?
|
Italy | 1 | 2005 | 805 | 0.020 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 152 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 5369 | 0.020 |
Why?
|
Transfection | 1 | 2011 | 6081 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 765 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1487 | 0.010 |
Why?
|
Cell Lineage | 1 | 2012 | 2589 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2007 | 919 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2008 | 4438 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20761 | 0.010 |
Why?
|
Antibodies | 1 | 2010 | 2426 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13219 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2008 | 792 | 0.010 |
Why?
|
Male | 7 | 2021 | 350143 | 0.010 |
Why?
|
Female | 8 | 2021 | 377052 | 0.010 |
Why?
|
Viruses | 1 | 2004 | 357 | 0.010 |
Why?
|
Markov Chains | 1 | 2004 | 991 | 0.010 |
Why?
|
Chromatin | 1 | 2012 | 2678 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2005 | 1894 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3423 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3480 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2592 | 0.010 |
Why?
|
Middle Aged | 5 | 2021 | 214639 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4070 | 0.010 |
Why?
|
Carcinoma | 1 | 2011 | 2319 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2001 | 408 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2644 | 0.010 |
Why?
|
Robotics | 1 | 2006 | 851 | 0.010 |
Why?
|
Remission Induction | 1 | 2005 | 2392 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2001 | 798 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 5046 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2974 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23482 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39334 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58293 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5190 | 0.010 |
Why?
|
Menstrual Cycle | 1 | 2001 | 533 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 51354 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3765 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11664 | 0.010 |
Why?
|
Aged | 3 | 2021 | 162392 | 0.010 |
Why?
|
Cell Communication | 1 | 2003 | 1633 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11139 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10600 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2001 | 1156 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6476 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9960 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4748 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 12929 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 14154 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6631 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 70931 | 0.010 |
Why?
|
Zebrafish | 1 | 2005 | 2998 | 0.010 |
Why?
|
Bacteria | 1 | 2004 | 2113 | 0.010 |
Why?
|
Rats | 1 | 2008 | 24794 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2005 | 12495 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4395 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 13209 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15185 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 22636 | 0.000 |
Why?
|
Inflammation | 1 | 2003 | 10090 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 85064 | 0.000 |
Why?
|